LENZ logo

LENZ Therapeutics, Inc. (LENZ)

Profile

Full Name

LENZ Therapeutics, Inc.

Ticker

NASDAQ: LENZ

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 22, 2024

Indexes

Not included

Website

https://www.lenz-tx.com

Employees

6

Key Details

Price

$39.85(+3.40%)

Market cap

Last Dividend

$1.03

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$2.34(+93.45% YoY)

PE ratio

-

Next earnings date

Oct 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $39.85
    LENZ price is $39.85

    30-Day Relative Volume

    0.71
    LENZ 30-day relative volume is 0.71

    Price Performance

    Price Most recent change

    +3.4%
    LENZ price was up +3.4% on Aug 21, 2025

    Price YTD change

    +38.03%
    LENZ price is up +38.03% since January 1st

    Price 1-year change

    +77.35%
    LENZ price is up +77.35% year-on-year

    Price 3-year change

    +1016.25%
    LENZ price is up +1016.25% over the past 3 years

    Price Range

    Price All-time high

    $41.70
    LENZ price is currently -4.44% below its historical high of $41.70

    Price 3-year low

    $1.59
    LENZ price is currently +2406.29% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.14B
    LENZ market capitalization is $1.14 billion

    Market cap 3-year change

    +3728.53%
    LENZ market capitalization is up +3728.53% over the past 3 years

    Market cap All-time high

    $1.17B
    LENZ market capitalization is currently -2.59% below its historical high of $1.17 billion

    Market cap sector rank

    74.52%
    LENZ market capitalization is higher than 74.52% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.73%
    LENZ shares outstanding is up +3.73% year-on-year

    Shares Outstanding 3-Year Change

    +242.98%
    LENZ shares outstanding is up +242.98% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.66
    LENZ beta is 1.66

    200-day SMA

    $28.90
    LENZ price is currently +37.91% above its 200-day simple moving average

    50-day SMA

    $32.78
    LENZ price is currently +21.58% above its 50-day simple moving average

    RSI

    63.02
    LENZ 14-day relative strength index is 63.02

    Volume

    0.71
    LENZ 30-day relative volume is 0.71

    ATR

    $2.95
    LENZ average true range is $2.95

    10-day Historical Volatility

    100.40%
    LENZ 10-day historical volatility is 100.40%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $1.03
    LENZ last dividend was $1.03 per share, with an ex-dividend date of March 22, 2024

    Next Dividend

    -
    LENZ next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $1.03
    LENZ annual dividend per share is $1.03

    Dividend per share Sector Rank

    40.91%
    LENZ annual dividend per share is higher than 40.91% of companies in Healthcare sector

    Dividend per share 1-Year Change

    -
    LENZ annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    LENZ annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    2.58%
    LENZ annual dividend yield is 2.58%

    Dividend yield Sector Rank

    59.09%
    LENZ annual dividend yield is higher than 59.09% of companies in Healthcare sector

    Other

    Payout ratio

    0.00%
    LENZ annual payout ratio is 0.00%

    Dividends paid

    $0.00
    LENZ annual dividends paid is $0.00

    Free cash flow

    -$59.86M
    LENZ annual free cash flow is -$59.86 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    LENZ annual revenue is $0.00

    Revenue Analysts estimate

    $13.88M
    LENZ annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    0%
    LENZ annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.61%
    LENZ annual revenue is higher than 28.61% of companies in Healthcare sector

    EPS

    EPS

    -$2.34
    LENZ annual earnings per share is -$2.34

    EPS Analysts estimate

    -$2.56
    LENZ annual earnings per share is currently -8.44% lower than the consensus analysts' forecast

    EPS 1-year change

    +93.45%
    LENZ annual earnings per share is up +93.45% year-on-year

    EPS Sector rank

    34.8%
    LENZ annual earnings per share is higher than 34.8% of companies in Healthcare sector

    Profit

    Gross profit

    -$58.00K
    LENZ annual gross profit is -$58.00 thousand

    Gross margin

    -
    LENZ annual gross profit margin value is unknown

    Operating profit

    -$58.61M
    LENZ annual operating income is -$58.61 million

    Operating margin

    -
    LENZ annual operating profit margin value is unknown

    Net income

    -$49.77M
    LENZ annual net profit is -$49.77 million

    Net margin

    -
    LENZ annual net profit margin value is unknown

    Expenses

    Total expenses

    $49.77M
    LENZ annual total expenses is $49.77 million

    Operating expenses

    $58.55M
    LENZ annual total operating expenses is $58.55 million

    Cost of goods sold

    $58.00K
    LENZ annual cost of goods sold is $58.00 thousand

    Selling, general & administrative expenses

    $0.00
    LENZ annual SGA is $0.00

    Depreciation and amortization

    $58.00K
    LENZ annual depreciation & amortization is $58.00 thousand

    Interest expense

    $0.00
    LENZ annual interest expense is $0.00

    Income tax

    $1000.00
    LENZ annual income tax is $1000.00

    EBIT & EBITDA

    EBIT

    -$58.61M
    LENZ annual earnings before interest & taxes is -$58.61 million

    EBITDA

    -$58.55M
    LENZ annual EBITDA is -$58.55 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $215.30M
    LENZ annual total assets is $215.30 million

    Non current assets

    $3.39M
    LENZ annual long term assets is $3.39 million

    Current assets

    $211.92M
    LENZ annual total current assets is $211.92 million

    Cash and cash equivalents

    $209.14M
    LENZ annual cash & cash equivalents is $209.14 million

    Accounts receivable

    -
    LENZ annual accounts receivable value is unknown

    Inventory

    $0.00
    LENZ annual inventory is $0.00

    Liabilities

    Total liabilities

    $11.22M
    LENZ annual total liabilities is $11.22 million

    Long term liabilities

    $814.00K
    LENZ annual total long term liabilities is $814.00 thousand

    Current liabilities

    $10.41M
    LENZ annual total current liabilities is $10.41 million

    Accounts payable

    $4.26M
    LENZ annual accounts payable is $4.26 million

    Debt

    Total debt

    $1.38M
    LENZ annual total debt is $1.38 million

    Total debt 1-year change

    +319.76%
    LENZ annual total debt is up +319.76% year-on-year

    Long term debt

    $814.00K
    LENZ annual long term debt is $814.00 thousand

    Short term debt

    $567.00K
    LENZ annual short term debt is $567.00 thousand

    Equity & Capital

    Shareholders equity

    $204.08M
    LENZ annual stockholders equity is $204.08 million

    Book value

    $204.08M
    LENZ annual book value is $204.08 million

    Retained earnings

    -$145.01M
    LENZ annual retained earnings is -$145.01 million

    Working capital

    $201.51M
    LENZ annual working capital is $201.51 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$59.39M
    LENZ annual cash flow from operations is -$59.39 million

    Cash from operations 1-year change

    +1.64%
    LENZ annual cash flow from operations is up +1.64% year-on-year

    Cash from investing

    -$154.48M
    LENZ annual cash flow from investing activities is -$154.48 million

    Cash from investing 1-year change

    -421.52%
    LENZ annual cash flow from investing activities is down -421.52% year-on-year

    Cash from financing

    $199.00M
    LENZ annual cash flow from financing activities is $199.00 million

    Cash from financing 1-year change

    +146.59%
    LENZ annual cash flow from financing activities is up +146.59% year-on-year

    CAPEX

    CAPEX

    $468.00K
    LENZ annual capital expenditures is $468.00 thousand

    CAPEX 1-year change

    +1460%
    LENZ annual capital expenditures is up +1460% year-on-year

    Free Cash Flow

    Free cash flow

    -$59.86M
    LENZ annual free cash flow is -$59.86 million

    Free cash flow 1-year change

    +0.91%
    LENZ annual free cash flow is up +0.91% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    LENZ annual gross profit margin value is unknown

    Operating margin

    -
    LENZ annual operating profit margin value is unknown

    Net margin

    -
    LENZ annual net profit margin value is unknown

    ROA & ROE

    ROA

    -34.84%
    LENZ annual return on assets is -34.84%

    ROE

    -39.07%
    LENZ annual return on equity is -39.07%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    LENZ price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    LENZ price to earnings ratio is unknown

    PB Ratio

    PB ratio

    5.51
    LENZ price to book ratio is 5.51

    PB ratio Sector rank

    80.33%
    LENZ price to book ratio is higher than 80.33% of companies in Healthcare sector

    PS Ratio

    PS ratio

    227.32
    LENZ price to sales ratio is 227.32

    PS ratio Sector rank

    93.22%
    LENZ price to sales ratio is higher than 93.22% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $928.02M
    LENZ enterprise value is $928.02 million

    Enterprise value Sector rank

    73.7%
    LENZ enterprise value is higher than 73.7% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -15.00
    LENZ EV/EBITDA is -15.00

    EV/EBITDA Sector rank

    8.82%
    LENZ EV/EBITDA is higher than 8.82% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    20.36
    LENZ annual current ratio is 20.36

    Quick ratio

    20.36
    LENZ annual quick ratio is 20.36

    Leverage

    Debt to equity

    0.01
    LENZ annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    LENZ annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    LENZ piotroski f-score value is unknown

    Altman Z-Score

    60.06
    LENZ altman z-score is 60.06

    Analyst ratings

    Recent major analysts updates

    Aug 1, 25 HC Wainwright & Co.
    Buy
    Aug 1, 25 Citigroup
    Buy
    Jul 31, 25 Raymond James
    Outperform
    Jul 31, 25 Citigroup
    Buy
    Jul 28, 25 HC Wainwright & Co.
    Buy
    May 8, 25 HC Wainwright & Co.
    Buy
    Apr 16, 25 HC Wainwright & Co.
    Buy
    Apr 14, 25 Piper Sandler
    Overweight
    Mar 20, 25 Citigroup
    Buy
    Nov 7, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with LENZ included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for LENZ Therapeutics, Inc.?
    • Does LENZ Therapeutics, Inc. pay dividends?
    • What sector is LENZ Therapeutics, Inc. in?
    • What industry is LENZ Therapeutics, Inc. in?
    • What country is LENZ Therapeutics, Inc. based in?
    • When did LENZ Therapeutics, Inc. go public?
    • Is LENZ Therapeutics, Inc. in the S&P 500?
    • Is LENZ Therapeutics, Inc. in the NASDAQ 100?
    • Is LENZ Therapeutics, Inc. in the Dow Jones?
    • When was LENZ Therapeutics, Inc.'s last earnings report?
    • When does LENZ Therapeutics, Inc. report earnings?

    What is the ticker symbol for LENZ Therapeutics, Inc.?

    The ticker symbol for LENZ Therapeutics, Inc. is NASDAQ:LENZ

    Does LENZ Therapeutics, Inc. pay dividends?

    No, LENZ Therapeutics, Inc. does not pay dividends

    What sector is LENZ Therapeutics, Inc. in?

    LENZ Therapeutics, Inc. is in the Healthcare sector

    What industry is LENZ Therapeutics, Inc. in?

    LENZ Therapeutics, Inc. is in the Biotechnology industry

    What country is LENZ Therapeutics, Inc. based in?

    LENZ Therapeutics, Inc. is headquartered in United States

    When did LENZ Therapeutics, Inc. go public?

    LENZ Therapeutics, Inc.'s initial public offering (IPO) was on March 22, 2024

    Is LENZ Therapeutics, Inc. in the S&P 500?

    No, LENZ Therapeutics, Inc. is not included in the S&P 500 index

    Is LENZ Therapeutics, Inc. in the NASDAQ 100?

    No, LENZ Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is LENZ Therapeutics, Inc. in the Dow Jones?

    No, LENZ Therapeutics, Inc. is not included in the Dow Jones index

    When was LENZ Therapeutics, Inc.'s last earnings report?

    LENZ Therapeutics, Inc.'s most recent earnings report was on May 8, 2025

    When does LENZ Therapeutics, Inc. report earnings?

    The next expected earnings date for LENZ Therapeutics, Inc. is October 29, 2025
    On this page